Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-03-18Clinical Trial Update: TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors [Phase 1, Phase 2]
Tarus Therapeutics has withdrawn its TT-4 single-agent trial in advanced solid tumors across Phase 1 and Phase 2. The listed conditions incl…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer
This clinical trial update describes a study evaluating robotic-assisted surgery with Vessel Sealer Extend for locally advanced gastric canc…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) [Phase 3]
Phase 3 trial MK-3475-811/KEYNOTE-811 evaluating pembrolizumab plus placebo with trastuzumab and chemotherapy in HER2-positive advanced gast…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer
A clinical trial update from Regina Elena Cancer Institute describes a study to identify molecular traits of non-canonical responders to per…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Efficacy and Safety of ESD for the Treatment of Superficial Gastric Neoplasms
This clinical trial update describes an ongoing study evaluating the efficacy and safety of endoscopic submucosal dissection (ESD) for super…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer [Phase 2]
Phase 2 randomized study comparing regorafenib maintenance to placebo in metastatic gastric cancer patients who did not progress after first…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial [Phase 2]
Phase 2 trial (NCT04510064) evaluated camrelizumab combined with nab-POF chemotherapy in patients with initially unresectable locally advanc…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer [Phase 1, Phase 2]
A clinical trial update describes a planned first-line treatment for advanced gastric cancer using Fruquintinib in combination with a PD-1 i…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Blood Tests for Gastritis and Gastric Neoplasms
A completed clinical trial examining blood-based tests for detecting gastritis and gastric neoplasms has posted results.
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: The Effect of Post-operative Exercise in Gastric Cancer Patients: A Randomized Controlled Trial (RCT) Study [NA]
This randomized controlled trial investigates post-operative exercise in gastric cancer patients. The study has completed, but results are n…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Expanded Indications of Endoscopic Submucosal Dissection for Early Gastric Cancer in China
A completed clinical trial reports expanded indications for endoscopic submucosal dissection to treat early gastric cancer in China.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Energy CT in Imaging and Diagnosis of Gastric Cancer
A clinical trial evaluating Energy CT for imaging and diagnosis of gastric cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. [Phase 1]
A Phase 1 trial testing BC001 with Sintilimab and the XELOX regimen for HER-2 negative advanced/metastatic gastric cancer or gastroesophagea…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)
A clinical trial evaluating the Luso-Cor stent compared to other endoscopic techniques for managing fistulas and anastomotic dehiscences; cu…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer [Phase 2]
Phase 2 clinical trial evaluating Taxol (paclitaxel) given intravenously and intraperitoneally with Tasigna (nilotinib) taken orally for per…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep Learning
This registry entry outlines an ongoing study to develop a predictive deep-learning model for gastric cancer peritoneal metastasis and cache…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Safety of 250ml Preoperative Carbohydrate Drink in Gastric Cancer Patients [NA]
Completed clinical trial assessing the safety of a 250 ml preoperative carbohydrate drink in gastric cancer patients.
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma [Phase 2, Phase 3]
A phase 2/3 trial of preoperative therapy for gastric and gastroesophageal junction adenocarcinoma is currently active but not recruiting. T…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer
A clinical trial update describing a study on the association between microplastics, macrogenomics, and metabolomics in gastric cancer, curr…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer
This document reports a clinical trial evaluating nivolumab in combination with chemotherapy as first-line treatment for adults with advance…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome
A clinical trial update assessing how environmental factors, including air pollution, affect gastric cancer, with the study currently active…
-
FDA approval · 2025-02-28FDA Approved: ONTRUZANT — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ONTRUZANT (trastuzumab) by Organon LLC. This document confirms the supplemental approval for the…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
This clinical trial update describes a prospective evaluation and molecular profiling of gastric tumors (gastric cancer), with the study sta…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Personalized DC Vaccine for Postoperative Cancer [Phase 1]
A Phase 1 clinical trial evaluating a personalized dendritic cell vaccine for postoperative gastric cancer and hepatocellular carcinoma is c…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Personalised Health Recommendations to the General Population Through an Integrated AI Guided [NA]
A ClinicalTrials.gov entry funded by Fundación para la Investigación del Hospital Clínico de Valencia describes an AI-guided program to deli…